(Q74177798)
Statements
Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4 (English)
Kleinman EF
Campbell E
Giordano LA
Cohan VL
Jenkinson TH
Cheng JB
Shirley JT
Pettipher ER
Salter ED
Hibbs TA
DiCapua FM